|
A technique
that combines high-level magnetic resonance imaging (MRI) with
a new spectroscopic method may make it possible to diagnose breast
cancer without having to perform a biopsy.
In this technique,
being developed by researchers at the University of Minnesota,
MRI is used to detect breast lumps, while spectroscopy measures
levels of choline (tCho) compounds known to accumulate in cancer
cells.
"We found
tCho concentrations to be significantly higher in malignancies
than in benign lumps and normal breast tissues using this quantitative
method," said lead researcher Michael Garwood.
Currently,
the presence of a breast tumor is confirmed by surgically taking
a sample of tissue and analyzing it in a laboratory. The new method
may eventually reduce the need to perform these biopsies.
"Using
high magnetic fields and this spectroscopic technique may produce
a powerful way to diagnose breast cancer and to monitor its response
to treatment," Garwood said. "We hope this technique
will eventually be used to avoid unnecessary biopsy."
Reporting
on their study in the journal Magnetic Resonance in Medicine,
the researchers said they thus far have measured tCho levels in
normal breast tissue and in benign and malignant lesions in 105
women.
The study
remains open to women who have a suspicious breast lump; however,
MRI and MRS scanning must occur before a biopsy or surgery on
the lump has been performed.
Women interested
in participating in the study can call 612-273-1944.
Other
Sources: University of Minnesota
|